JP6980419B2 - AGEs産生抑制剤 - Google Patents
AGEs産生抑制剤 Download PDFInfo
- Publication number
- JP6980419B2 JP6980419B2 JP2017115595A JP2017115595A JP6980419B2 JP 6980419 B2 JP6980419 B2 JP 6980419B2 JP 2017115595 A JP2017115595 A JP 2017115595A JP 2017115595 A JP2017115595 A JP 2017115595A JP 6980419 B2 JP6980419 B2 JP 6980419B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- mango
- leaves
- ages
- tetrahydroxybenzophenone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 44
- 239000003112 inhibitor Substances 0.000 title claims description 12
- 235000014826 Mangifera indica Nutrition 0.000 claims description 29
- 235000004936 Bromus mango Nutrition 0.000 claims description 28
- 235000009184 Spondias indica Nutrition 0.000 claims description 28
- BZYKNVLTMWYEFA-ZJKJAXBQSA-N (4-hydroxyphenyl)-[2,4,6-trihydroxy-3-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]methanone Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C(C(=O)C=2C=CC(O)=CC=2)=C1O BZYKNVLTMWYEFA-ZJKJAXBQSA-N 0.000 claims description 13
- BZYKNVLTMWYEFA-JGPIWLIHSA-N (4-hydroxyphenyl)-[2,4,6-trihydroxy-3-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]methanone Chemical compound C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)C=1C(=C(C(=O)C2=CC=C(C=C2)O)C(=CC=1O)O)O BZYKNVLTMWYEFA-JGPIWLIHSA-N 0.000 claims description 8
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 239000000284 extract Substances 0.000 description 29
- 241001093152 Mangifera Species 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 235000013305 food Nutrition 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 229930002875 chlorophyll Natural products 0.000 description 10
- 235000019804 chlorophyll Nutrition 0.000 description 10
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 10
- 239000012965 benzophenone Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 229930182476 C-glycoside Natural products 0.000 description 7
- -1 benzophenone C-glycoside Chemical class 0.000 description 7
- 239000000945 filler Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000036252 glycation Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 150000008494 α-glucosides Chemical class 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 150000008495 β-glucosides Chemical class 0.000 description 3
- AOJWDTJDEGSHOA-UHFFFAOYSA-N (4-hydroxyphenyl)-(2,4,6-trihydroxyphenyl)methanone Chemical compound C1=CC(O)=CC=C1C(=O)C1=C(O)C=C(O)C=C1O AOJWDTJDEGSHOA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XCYPSOHOIAZISD-MLWJPKLSSA-N N(6)-(1-carboxyethyl)-L-lysine Chemical compound OC(=O)C(C)NCCCC[C@H](N)C(O)=O XCYPSOHOIAZISD-MLWJPKLSSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001056 green pigment Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000740650 Bubalus carabanensis Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- DCPBQSFZQHFSMR-QMMMGPOBSA-N argpyrimidine Chemical compound CC1=NC(NCCC[C@H](N)C(O)=O)=NC(C)=C1O DCPBQSFZQHFSMR-QMMMGPOBSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 108010089180 iriflophenone Proteins 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
実験材料および被検体:実験材料は近畿大学附属農場湯浅農場にて栽培されているマンゴー(採取対象;250本、樹高;2 m、樹齢;18-26年)から採取したものを実験に供した。乾燥した実験材料をそれぞれクラッシュミルを用いて細切後、20倍量のメタノール(花のみ10倍量)に浸漬し、72時間室温抽出した。抽出溶媒は抽出を均一にさせるため24時間に1回数分程度撹拌し、合計72時間抽出を行った。抽出後、No.5 A濾紙(110 mm ADVANTEC)にて濾過し、残渣を除去した。得られたろ液を減圧下で溶媒を留去してエキスを得た。
なお、葉(緑色葉)、果皮、種子、果肉および花のエキス収率は、それぞれ23、23、6、63、23%であった。
いずれの葉(緑色葉)も近畿大学附属農場湯浅農場にて栽培されているマンゴーから採取したものを実験に供した。エキス収率は乾燥葉50 gに対して、上記アーウィン種葉と同じ抽出方法で取得した。エキス収率は、アルフォンソ種:16%、エドワード種:22%、トミーアトキンス種:20%であった。
AGE産生抑制試験はShimodaらの方法に準じて行った。すなわち、被検体はDMSOに溶解した(DMSO最終濃度;10%)。2 mlチューブに被検液100μlおよび1/5M のリン酸緩衝液(PBS,pH 7.2)に溶解した10% D-glucoseと1% BSAの混合液900μlをそれぞれ加え,60℃,48時間インキュベートした溶液を黒色96wellプレートに移し,蛍光強度(励起波長 370nm/蛍光波長 460nm)をマルチラベルリーダー(PerkinElmer 2030 ARVO X4,PerkinElmer Life and Analytical Sciences)により測定した。混合液非添加群は混合液の代わりにPBSを用いた。AGE産生抑制率(%)は、以下の式により算出した。陽性対照薬としては、aminoguanidine hydrochloride(アミノグアニジン塩酸塩)を用いた。下記表1は、AGE産生を50%阻害するために必要な濃度(IC50値)である。
A:混合液(glucoseとBSA)添加、DMSO添加群(60℃,48時間インキュベート)の測定値、
B:混合液添加、DMSO添加群(4℃,48時間インキュベート)の測定値、
C:混合液添加および被検液添加群の測定値、
D;混合液非添加,被検液添加群の測定値。
葉エキス(緑色葉)を粗分画するため、葉エキスをオープンカラムクロマトグラフィーに供した。充填剤にはシリカゲル(Wakogel C-100, Wako)を使用した。試料(葉エキス;5.4g)に対して20倍量の充填剤を用意し、クロロホルムを用いて湿式充填法によりオープンカラムクロマト管(φφの充填剤を用意し)に充填した。次に、メタノール抽出物を10倍量の充填剤に吸着させるため、少量のメタノールに溶解し吸着用充填剤と混合した。メタノールを除くため、ロータリーエバポレーターを用い減圧留去した。乾燥後の充填剤をクロロホルムに懸濁しカラムに供した。溶出溶媒はオープンカラムクロマト管に充填した充填剤の体積に対して5倍量の溶媒を用い、クロロホルム:メタノール=10:0 , 30:1, 10:1, 5:1, 0:10の順に溶出を行った。
3-C-β-D-Glucosyl-2,4,4',6-tetrahydroxybenzophenoneの同定は、Severiらの報告(2009)にある1Hおよび13C-NMR並びにマススペクトルに一致したことにより支持された。また、3-C-β-D-glucosyl-2,4,4',6-tetrahydroxybenzophenone含量は、205.9±7.6mg/gであった。
Claims (2)
- AGEs産生抑制剤の製造のための、マンゴー葉から単離された、3-Glucosyl-2,4,4',6-tetrahydroxybenzophenoneの使用。
- 前記3-Glucosyl-2,4,4',6-tetrahydroxybenzophenoneが、3-C-β-D-Glucosyl-2,4,4',6-tetrahydroxybenzophenoneであることを特徴とする、請求項1の使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017115595A JP6980419B2 (ja) | 2017-06-13 | 2017-06-13 | AGEs産生抑制剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017115595A JP6980419B2 (ja) | 2017-06-13 | 2017-06-13 | AGEs産生抑制剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019001725A JP2019001725A (ja) | 2019-01-10 |
JP6980419B2 true JP6980419B2 (ja) | 2021-12-15 |
Family
ID=65007228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017115595A Active JP6980419B2 (ja) | 2017-06-13 | 2017-06-13 | AGEs産生抑制剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6980419B2 (ja) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010077123A (ja) * | 2008-08-29 | 2010-04-08 | Hayashikane Sangyo Kk | メイラード反応阻害剤 |
-
2017
- 2017-06-13 JP JP2017115595A patent/JP6980419B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019001725A (ja) | 2019-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sagrillo et al. | Tucuma fruit extracts (Astrocaryum aculeatum Meyer) decrease cytotoxic effects of hydrogen peroxide on human lymphocytes | |
Wittenauer et al. | Characterisation and quantification of xanthones from the aril and pericarp of mangosteens (Garcinia mangostana L.) and a mangosteen containing functional beverage by HPLC–DAD–MSn | |
Mohd-Esa et al. | Antioxidant activity in different parts of roselle (Hibiscus sabdariffa L.) extracts and potential exploitation of the seeds | |
Gundogdu et al. | Determination of fruit chemical properties of Morus nigra L., Morus alba L. and Morus rubra L. by HPLC | |
Ma et al. | Extraction solvent affects the antioxidant, antimicrobial, cholinesterase and HepG2 human hepatocellular carcinoma cell inhibitory activities of Zanthoxylum bungeanum pericarps and the major chemical components | |
Ou et al. | Application of an online post-column derivatization HPLC-DPPH assay to detect compounds responsible for antioxidant activity in Sonchus oleraceus L. leaf extracts | |
Coy-Barrera | Analysis of betalains (betacyanins and betaxanthins) | |
JP6521949B2 (ja) | 黒ショウガ油脂抽出物及びその製造方法 | |
da Silva Andrade et al. | Antioxidant and antifungal activity of carnauba wax powder extracts | |
Oliveira et al. | Evaluation of antioxidant capacity of the aqueous extract of Cynara scolymus L.(Asteraceae) in vitro and in Saccharomyces cerevisiae | |
Yunusa et al. | DPPH RADICAL SCAVENGING ACTIVITY AND TOTAL PHENOLIC CONTENT OF RAMBUTAN (Nephelium lappaceum) PEEL AND SEED. | |
Mann et al. | Evaluation of nutritional and phytochemical profiling of Baccaurea ramiflora Lour. syn. Baccaurea sapida (Roxb.) Mull. Arg. fruits | |
Frum et al. | Identification and quantification of phenolic compounds from red grape pomace | |
Zavala-Ocampo et al. | Acetylcholinesterase inhibition and antioxidant activity properties of Petiveria alliacea L. | |
Pathak¹ et al. | Pharmacognostical study of Anethum sowa (dill) seed | |
Zekri et al. | Extracts of M. pulegium (L.) and M. spicata (L.): Effect of extraction conditions on phenolics and flavonoïds contents and their antioxidant power | |
Lim et al. | Antioxidant activity and total phenolic content of different varieties of Portulaca grandiflora | |
JP5627585B2 (ja) | カナクギノキ由来抽出物、分画物または、化合物を含有する皮膚美白用組成物 | |
JP6980419B2 (ja) | AGEs産生抑制剤 | |
WO2017103838A1 (en) | A solvent free sesamin complex 90% and a method of synthesizing the same | |
Yusuf et al. | Isolation of epicatechin from the stem bark of Neocarya macrophylla (Sabine) Prance (Chrysobalanaceae) | |
Dhanmane et al. | Isolation of karanjin from Pongamia pinnata and its identification by difference analytical techniques | |
Ibrahim et al. | Successive solvent extraction and free radical scavenging activity of Azadirachta indica A. juss | |
JP5567499B2 (ja) | ラン科植物から分離した新規物質、これを含む抽出物、抗酸化剤、抗菌剤、抗癌剤及び抗炎症剤 | |
Choi et al. | Comparison of the antioxidative effects and content of anthocyanin and phenolic compounds in different varieties of Vitis vinifera ethanol extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200402 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210413 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210610 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210610 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210824 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210830 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211109 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6980419 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |